Amy K. Keating

Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia.

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Thymoma in children: report of 2 cases and review of the literature.

Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.

Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.

Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.

Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.

Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.

Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.

TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.